GH
PCRX icon

GAM Holding’s Pacira BioSciences PCRX Stock Holding History

GAM Holding’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,404
Closed -$539K – 874
2019
Q2 		$539K Buy
+12,404
New +$527K 0.02% 660
2016
Q1 		– Sell
-47,700
Closed -$3.66M – 1033
2015
Q4 		$3.66M Hold
47,700
– – 0.06% 345
2015
Q3 		$1.96M Hold
47,700
– – 0.03% 491
2015
Q2 		$3.37M Buy
47,700
+17,000
+55% +$1.34M 0.05% 381
2015
Q1 		$2.73M Buy
30,700
+10,700
+54% +$1.09M 0.04% 433
2014
Q4 		$1.77M Buy
+20,000
New +$1.89M 0.03% 542

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return